Novel transcript, antisense to FAT1

ENSG00000308165 is an uncharacterized long noncoding RNA (lncRNA) gene, described as a novel transcript antisense to FAT1. It is not a protein-coding gene and does not match established pharmacological targets such as enzymes, receptors, or channels. There is currently no known biological or disease relevance, and no evidence that it interacts with drugs or is usable as a biomarker. This entry is systematic, likely curated by transcriptome annotation pipelines, and lacks clinical or mechanistic data. All available information is insufficient for structured drug target annotation[3]. The gene most associated with FAT1 is FAT atypical cadherin 1, a large cadherin implicated in cancer and cell signaling[1][2][4][5], but the transcript in question is distinct from this protein-coding gene and does not encode the FAT1 protein. Note: This entry is likely a misinterpretation or placeholder for an experimental or computationally predicted transcript, not a validated molecular entity for therapeutic drug discovery.